The price gap for Harvoni, a hepatitis C medication, between the US and Germany is due to multiple factors. In the US, drug prices are often negotiated by various parties, leading to higher costs. Germany's single-payer system and stricter regulations result in lower medication prices. Additionally, market dynamics and differences in healthcare structures contribute to the significant price difference observed